Sustaining individuals and communities
Our generators are designed and built by us and we maintain premium quality control on every unit. Our destruct system works by removing surplus ozone to increase safety and decrease the time required to cleanse the area.
Read More →Nara Medical University in Japan Announces World’s First Result of Research on SARS-CoV-2 and Ozone with MBT Consortium Association The research group consisted of; Professor Hisakazu YANO, Department of Microbiology and Infectious Diseases, Nara Medical University Director Kei KASAHARA, Center for Infectious Disease), Nara Medical University MBT Consortium Association (Infectious Diseases subcommittee member: Qol Holdings …
Read More →Ticks all the boxes, Permanently Removes all Odours, Kills Bacteria, Destroys Viruses, Carbon and Energy Consumption – Sustainability, Circular Economy, Rapid ROI, Healthier Environment, Better Customer service and Track record.
Read More →According to Wikipedia, formaldehyde is a naturally occurring organic compound. The pure compound is a pungent-smelling colourless gas that polymerises spontaneously into paraformaldehyde, hence it is stored as an aqueous solution.
Read More →If that is the case then you could probably be in need of a deep clean by your local valet company. Unfortunately valets are expensive, time consuming and more often than not only ever mask the issue of a strong odour from the car because they do not deal with the cause as well as involving a high chemical content.
Read More →The Food and Drug Administration (FDA) is expected to authorize the Pfizer-BioNTech COVID-19 vaccine for children and teens between 12 and 15 years old by early next week.
This is according to federal officials who spoke to The New York Times.
In early April, Pfizer-BioNTech requested an amendment of the existing emergency use authorization (EUA) to expand use of the vaccine to this younger age group.
Right now, their vaccine is only approved in the United States for those 16 years old and over.
The FDA is currently reviewing data submitted by Pfizer and BioNTech.
The companies reported at the end of March that a phase 3 clinical trial involving 2,260 12- to 15-year-olds showed that the vaccine had an efficacy of 100 percent in this age group. It was also well tolerated.
Copyright© 2002-2025 visuallink© SaaS - Web Hosted Solutions, Design and Maintenance by Visual Link IT Pty Ltd - Software Solutions